Skip to main content
Clinical Trials/NCT06229821
NCT06229821
Not yet recruiting
Not Applicable

Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants

Augusta University0 sites10 target enrollmentMarch 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Distress Syndrome in Premature Infant
Sponsor
Augusta University
Enrollment
10
Primary Endpoint
Mechanical ventilation and supplemental oxygen
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the benefits and safety of Intrapulmonary Percussive Ventilation in preterm infants. IPV has been demonstrated to be safe, and improve airway secretions clearance and decreased atelectasis in pediatric patients. We aim to evaluate the effects of IPV in preterm infants.

Registry
clinicaltrials.gov
Start Date
March 1, 2024
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michel Garcia Crespo

Principal Investigator

Augusta University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Mechanical ventilation and supplemental oxygen

Time Frame: From the date of starting treatment protocol to 2 weeks after.

Need for mechanical ventilation and supplemental oxygen administration

Secondary Outcomes

  • Diagnosis of Bronchopulmonary Dysplasia(At 36 weeks gestational age)

Similar Trials